Results 121 to 130 of about 72,056 (263)

Nurse-Led Clinic for Patients With Decompensated Liver Cirrhosis. [PDF]

JGH Open
Kelstrup EE, Andersen SH, Poulsen TL, Thomsen KL, Kazankov K, Bager P.   +5 more
europepmc   +1 more source

The Dynamic Evolution of Lipid Profiles Following Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis

Portal Hypertension &Cirrhosis, EarlyView.
Cirrhosis is frequently accompanied by varying degrees of lipid profile abnormalities. This study confirms that these profiles are differentially affected by disease etiology and progressively worsen—with significant reductions in TC, HDL‐C, and LDL‐C—as liver disease severity increases. TIPS improves lipid profiles, particularly by increasing HDL‐C in
Jiamin Xu, Qinnian Li, Lagan Kumar Manandhar, Bilian Zhu, Chenrui Zhang, Weimin Bao, Yingmei Tang   +6 more
wiley   +1 more source

Metabolic dysfunction associated steatotic liver disease: mechanisms, diagnosis, and management in adults. [PDF]

BMJ Med
Reinson T, Bilson J, Childs C, Buchanan RM, Targher G, Byrne CD.   +5 more
europepmc   +1 more source

Cirrhosis of the Liver: Alcoholic Paralysis [PDF]

BMJ, 1877
openaire   +2 more sources

Chinese Registry on Transjugular Intrahepatic Portosystemic Shunts (CN‐TIPS): Protocol for a Registry‐Based, Prospective Prognostic Study

Portal Hypertension &Cirrhosis, EarlyView.
CN‐TIPS is a nationwide, multicenter prospective registry that will enroll 10,000 adults with portal hypertension undergoing transjugular intrahepatic portosystemic shunt in China, integrating perioperative clinical and hemodynamic metrics with standardized imaging (including computational modeling in a dedicated subcohort) and multi‐omics biospecimens,
Yi Xiang, Yong Lv, Hongwei Zhou, Jianbo Zhao, Meng Niu, Jiacheng Liu, Guangchuan Wang, Qi Zhang, Weizhong Zhou, Beijia Yu, Jun Chi, Guo Han, Jiawei Zhang, Long Gao, Wenjing Liu, Zhang Zhang, Tianyu Liu, Wuhua Guo, He Zhao, Gao‐Jun Teng, Xiaolong Qi   +20 more
wiley   +1 more source

Hepatic Vascular Shunts Mimicking Malignant Lesions on ¹⁸F-FDG PET/CT Imaging: Interpretation Pitfall in the Background of Cirrhotic Liver. [PDF]

Mol Imaging Radionucl Ther
Jain S, Saad Eddin A, McNeely P, Graham M, Shariftabrizi A.   +4 more
europepmc   +1 more source

Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease

Portal Hypertension &Cirrhosis, EarlyView.
MASLD is the most prevalent chronic liver disease worldwide, yet effective pharmacological treatments remain limited. Hyperuricemia is now recognized as a key driver of hepatic steatosis, inflammation, and fibrosis, with elevated serum uric acid levels independently predicting hepatocellular carcinoma and liver‐related mortality.
Rong Wang, Zhenyu Liu, Jun Lin, Weijing Zhang, Xianzhi Liu, Tong Zhang   +5 more
wiley   +1 more source

Diagnostic Value of MR Elastography and MRI-Proton Density Fat Fraction in Cirrhosis Based on Explant Liver Histology. [PDF]

J Gastroenterol Hepatol
Min EK, Kim SS, Ahn B, Kim DG, Joo DJ, Ahn SH, Kim SU, Lee JG.   +7 more
europepmc   +1 more source

Association between sleep duration and cognitive function and emotional disorders in middle‐aged and elderly patients with cerebral small vessel disease

Sleep Research, EarlyView.
Abstract Objectives To investigate the association between the sleep duration with cognitive impairment in middle‐aged and elderly patients with cerebral small vessel disease (CSVD). Methods This cross‐sectional study enrolled hospitalized patients aged ≥55 years diagnosed with CSVD between November 2021 and August 2023.
Chunmei Long, Yunying Wu, Sha Wang, Ziwei Gong, Ye Wang   +4 more
wiley   +1 more source

Liver Cirrhosis and In-Hospital Outcomes in Patients With Sickle Cell Crises. [PDF]

EJHaem
Gold-Olufadi S, Ogunniyi K, Dorcas AO, Tabiti BF, Saparov D, Nwachukwu C, Becerra H, Bhavanam S, Neharika S, Ogedegbe J, Uche IN, Wang JC, Emeasoba CM, Jaamour D, Awoyemi T.   +14 more
europepmc   +1 more source